| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/25/2023 | -0.92% | Morgan Stanley | $15 → $14 | Maintains | Equal-Weight |
| 10/06/2023 | 13.23% | Telsey Advisory Group | $18 → $16 | Maintains | Outperform |
| 09/27/2023 | 13.23% | TD Cowen | → $16 | Initiates Coverage On | → Outperform |
| 07/27/2023 | 27.39% | Telsey Advisory Group | → $18 | Reiterates | Outperform → Outperform |
| 07/10/2023 | 6.16% | Morgan Stanley | $16 → $15 | Maintains | Equal-Weight |
| 07/07/2023 | -0.92% | Citigroup | $15 → $14 | Maintains | Neutral |
| 07/07/2023 | 20.31% | Stifel | $19 → $17 | Maintains | Buy |
| 07/07/2023 | 6.16% | Wells Fargo | $18 → $15 | Maintains | Overweight |
| 07/07/2023 | 27.39% | Telsey Advisory Group | $24 → $18 | Maintains | Outperform |
| 06/28/2023 | 69.85% | Telsey Advisory Group | → $24 | Reiterates | Outperform → Outperform |
| 04/10/2023 | 34.47% | Guggenheim | $22 → $19 | Maintains | Buy |
| 04/10/2023 | 13.23% | B of A Securities | $18 → $16 | Maintains | Neutral |
| 04/10/2023 | 34.47% | Stifel | $20 → $19 | Maintains | Buy |
| 04/10/2023 | 27.39% | Wells Fargo | $20 → $18 | Maintains | Overweight |
| 04/10/2023 | 69.85% | Telsey Advisory Group | → $24 | Reiterates | → Outperform |
| 03/30/2023 | 69.85% | Telsey Advisory Group | → $24 | Reiterates | → Outperform |
| 02/01/2023 | 41.54% | Wells Fargo | $19 → $20 | Maintains | Overweight |
| 01/23/2023 | 20.31% | JP Morgan | $19 → $17 | Downgrades | Overweight → Neutral |
| 01/18/2023 | 20.31% | B of A Securities | $19 → $17 | Downgrades | Buy → Neutral |
| 01/11/2023 | 20.31% | Citigroup | $19 → $17 | Downgrades | Buy → Neutral |
| 12/12/2022 | 20.31% | Goldman Sachs | $18 → $17 | Downgrades | Buy → Neutral |
| 11/29/2022 | 34.47% | JP Morgan | $20 → $19 | Maintains | Overweight |
| 10/13/2022 | 13.23% | Morgan Stanley | $19 → $16 | Maintains | Equal-Weight |
| 10/10/2022 | 34.47% | Citigroup | $27 → $19 | Maintains | Buy |
| 10/07/2022 | 91.08% | Guggenheim | $33 → $27 | Maintains | Buy |
| 10/07/2022 | 34.47% | Wells Fargo | $22 → $19 | Maintains | Overweight |
| 10/07/2022 | 69.85% | Telsey Advisory Group | $30 → $24 | Maintains | Outperform |
| 08/04/2022 | 34.47% | Morgan Stanley | → $19 | Downgrades | Overweight → Equal-Weight |
| 07/11/2022 | 34.47% | Morgan Stanley | $33 → $19 | Maintains | Overweight |
| 07/08/2022 | 112.31% | Evercore ISI Group | $40 → $30 | Maintains | Outperform |
| 07/08/2022 | 119.39% | UBS | $34 → $31 | Maintains | Buy |
| 07/08/2022 | 55.7% | JP Morgan | $27 → $22 | Maintains | Overweight |
| 07/08/2022 | 55.7% | Wells Fargo | $25 → $22 | Maintains | Overweight |
| 06/02/2022 | 84.01% | Stifel | $30 → $26 | Maintains | Buy |
| 04/07/2022 | 140.62% | UBS | $37 → $34 | Maintains | Buy |
| 04/07/2022 | 84.01% | Goldman Sachs | $30 → $26 | Maintains | Buy |
| 04/07/2022 | 91.08% | Citigroup | $28 → $27 | Maintains | Buy |
| 04/05/2022 | 76.93% | Wells Fargo | $28 → $25 | Maintains | Overweight |
| 01/27/2022 | 112.31% | Telsey Advisory Group | $34 → $30 | Maintains | Outperform |
| 01/27/2022 | 126.47% | JP Morgan | $31 → $32 | Maintains | Overweight |
| 08/30/2021 | 119.39% | Wells Fargo | → $31 | Initiates Coverage On | → Overweight |
| 08/02/2021 | 168.93% | Stifel | → $38 | Initiates Coverage On | → Buy |
| 07/14/2021 | 154.78% | Goldman Sachs | → $36 | Initiates Coverage On | → Buy |
| 07/12/2021 | 154.78% | Morgan Stanley | $28 → $36 | Maintains | Overweight |
| 07/09/2021 | 140.62% | Telsey Advisory Group | $32 → $34 | Maintains | Outperform |
| 04/12/2021 | 98.16% | Morgan Stanley | $25 → $28 | Maintains | Overweight |
| 04/09/2021 | 126.47% | Telsey Advisory Group | $27 → $32 | Maintains | Outperform |
| 04/01/2021 | 91.08% | Telsey Advisory Group | $24 → $27 | Maintains | Outperform |
| 02/04/2021 | 76.93% | Morgan Stanley | $22 → $25 | Maintains | Overweight |
| 12/10/2020 | 62.77% | Goldman Sachs | $11 → $23 | Upgrades | Sell → Buy |
| 11/10/2020 | 41.54% | B of A Securities | → $20 | Upgrades | Neutral → Buy |
| 10/12/2020 | 55.7% | Morgan Stanley | $18 → $22 | Upgrades | Equal-Weight → Overweight |
| 07/08/2020 | 27.39% | Morgan Stanley | $17 → $18 | Maintains | Equal-Weight |
| 04/09/2020 | 91.08% | UBS | $29 → $27 | Maintains | Buy |
| 04/08/2020 | 20.31% | Citigroup | $18 → $17 | Maintains | Buy |
| 04/08/2020 | 20.31% | Morgan Stanley | $23 → $17 | Maintains | Equal-Weight |
| 10/22/2019 | — | Macquarie | Initiates Coverage On | → Outperform | |
| 10/09/2019 | 55.7% | B of A Securities | $20 → $22 | Maintains | Buy |
| 08/15/2019 | 41.54% | B of A Securities | $25 → $20 | Upgrades | Neutral → Buy |
| 07/17/2019 | 34.47% | Goldman Sachs | $21 → $19 | Downgrades | Neutral → Sell |
| 04/15/2019 | 76.93% | B of A Securities | → $25 | Initiates Coverage On | → Neutral |
| 04/15/2019 | 98.16% | Telsey Advisory Group | → $28 | Initiates Coverage On | → Outperform |
| 04/15/2019 | — | Morgan Stanley | Initiates Coverage On | → Equal-Weight | |
| 04/15/2019 | 91.08% | Citigroup | → $27 | Initiates Coverage On | → Buy |
| 04/15/2019 | — | Goldman Sachs | Initiates Coverage On | → Neutral | |
| 04/15/2019 | — | JP Morgan | Initiates Coverage On | → Overweight | |
| 04/15/2019 | 84.01% | Guggenheim | → $26 | Initiates Coverage On | → Buy |
What is the target price for Levi Strauss (LEVI)?
The latest price target for Levi Strauss (NYSE: LEVI) was reported by Morgan Stanley on October 25, 2023. The analyst firm set a price target for $14.00 expecting LEVI to fall to within 12 months (a possible -0.92% downside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Levi Strauss (LEVI)?
The latest analyst rating for Levi Strauss (NYSE: LEVI) was provided by Morgan Stanley, and Levi Strauss maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Levi Strauss (LEVI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Levi Strauss, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Levi Strauss was filed on October 25, 2023 so you should expect the next rating to be made available sometime around October 25, 2024.
Is the Analyst Rating Levi Strauss (LEVI) correct?
While ratings are subjective and will change, the latest Levi Strauss (LEVI) rating was a maintained with a price target of $15.00 to $14.00. The current price Levi Strauss (LEVI) is trading at is $14.13, which is out of the analyst's predicted range.